参考文献:1. Kerin R. The hand in metastatic disease. J Hand Surg Am. 1987;12:77鈥?3. 363-5023(87)80164-8" target="_blank" title="It opens in new window">CrossRef 2. Amadio P, Lombardi R. Metastatic tumors of the hand. J Hand Surg Am. 1987;12:311鈥?. 363-5023(87)80299-X" target="_blank" title="It opens in new window">CrossRef 3. Rubens RD, Coleman RE. Bone metastases. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, editors. Clinical oncology. New York: Churchill Livingstone Inc.; 1995. p. 643鈥?5. 4. Moriwaki S. Bone metastasis and related diseases. 1st edition (in Japanese). Tokyo: Kinpodo and Company Inc; 1995. 5. Yamashita K, Ueda T, Komatsubara Y, Koyama H, Inaji H, Yonenobu K, Ono K. Breast cancer with bone-only metastases: visceral metastases-free rate in relation to anatomic distribution of bone metastases. Cancer. 1991;68:634鈥?. 3<634::AID-CNCR2820680332>3.0.CO;2-B" target="_blank" title="It opens in new window">CrossRef 6. Etoh T, Baba H, Taketomi A, Nakashima H, Kohnoe S, Seo Y, Fukuda T, Tomoda H. Diffuse bone metastasis with hematologic disorders from gastric cancer: clinicopathological features and prognosis. Oncol Rep. 1999;6:601鈥?. 7. Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br. 2005;87:698鈥?03. 302/0301-620X.87B5.15185" target="_blank" title="It opens in new window">CrossRef 8. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649鈥?5. 9. Tsai JY, Safran H. Status of treatment for advanced gastric carcinoma. Curr Oncol Rep. 2003;5:210鈥?. 3-0112-9" target="_blank" title="It opens in new window">CrossRef 10. Wu KK, Guise ER. Metastatic tumors of the hand: a report of six cases. J Hand Surg Am. 1978;3:271鈥?. 11. Rose BA, Wood FM. Metastatic bronchogenic carcinoma masquerading as a felon. J Hand Surg Am. 1983;8:325鈥?. 12. Gelberman RH, Menon J. The vascularity of the scaphoid bone. J Hand Surg Am. 1980;5:508鈥?3. 363-5023(80)80087-6" target="_blank" title="It opens in new window">CrossRef 13. Hsu CH, Yeh KH, Chen LT, Liu JM, Jan CM, Lin JT, Chen YC, Cheng AL. Weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition. Oncology. 1997;54:275鈥?0. CrossRef 14. Jeung HC, Rha SY, Shin SJ, Ahn JB, Noh SH, Roh JK, Chung HC. A phase II study of S-1 monotherapy administered for 2聽weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status. Br J Can. 2007;97:458鈥?3. 38/sj.bjc.6603902" target="_blank" title="It opens in new window">CrossRef 15. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: gastric cancer. Version 2. Fort Washington: NCCN; 2009. 16. Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gas Can. 2011;11:38鈥?5. 30/jgc.2011.11.1.38" target="_blank" title="It opens in new window">CrossRef
刊物类别:Medicine
刊物主题:Medicine & Public Health Orthopedics Surgical Orthopedics Conservative Orthopedics Rheumatology Sports Medicine